Therapeutic recommendations in HFE hemochromatosis for p.Cys282Tyr (C282Y/C282Y) homozygous genotype

Therapeutic recommendations in HFE hemochromatosis for p.Cys282Tyr (C282Y/C282Y) homozygous genotype

Although guidelines are available for hereditary hemochromatosis, a high percentage of the recommendations within them are not shared between the different guidelines. Our main aim is to provide an objective, simple, brief, and practical set of recommendations about therapeutic aspects of HFE hemoch...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:HEPATOLOGY INTERNATIONAL 2018-03, Vol.12 (2), p.83-86
Hauptverfasser: Adams, Paul, Altes, Albert, Brissot, Pierre, Butzeck, Barbara, Cabantchik, Ioav, Cançado, Rodolfo, Distante, Sonia, Evans, Patricia, Evans, Robert, Ganz, Tomas, Girelli, Domenico, Hultcrantz, Rolf, McLaren, Gordon, Marris, Ben, Milman, Nils, Nemeth, Elizabeta, Nielsen, Peter, Pineau, Brigitte, Piperno, Alberto, Porto, Graça, Prince, Dianne, Ryan, John, Sanchez, Mayka, Santos, Paulo, Swinkels, Dorine, Teixeira, Emerência, Toska, Ketil, Vanclooster, Annick, White, Desley
Format: Artikel
Sprache:eng
Schlagworte:
Chelation Therapy - methods
Colorectal Surgery
Diet
Female
Guidelines
Hemochromatosis
Hemochromatosis - genetics
Hemochromatosis - therapy
Hemochromatosis Protein - genetics
Hepatology
Homozygote
Humans
Male
Medicine
Medicine & Public Health
Phlebotomy - methods
Surgery
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Although guidelines are available for hereditary hemochromatosis, a high percentage of the recommendations within them are not shared between the different guidelines. Our main aim is to provide an objective, simple, brief, and practical set of recommendations about therapeutic aspects of HFE hemochromatosis for p.Cys282Tyr (C282Y/C282Y) homozygous genotype, based on the published scientific studies and guidelines, in a form that is reasonably comprehensible to patients and people without medical training. This final version was approved at the Hemochromatosis International meeting on 12th May 2017 in Los Angeles.
ISSN:1936-0533
1936-0541
DOI:10.1007/s12072-018-9855-0